详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Regulation of ERK and AKT pathways by hepatitis B virus X protein via Notch1 pathway in Hepatocellular Carcinoma

文献详情

资源类型：

作者：

单位： [1]Department of General Surgery, Zhongnan Hospital, Wuhan University, 169 Donghu Road, Wuhan 430071, China [2]Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China

出处：

DOI：

ISSN：

关键词： AKT ERK Hepatitis B virus X protein Hepatocellular carcinoma Notch1 pathway

摘要：

Hepatitis B virus (HBV) is the dominant risk factor for hepatocellular carcinoma (HCC). HBV X protein (HBx) plays crucial roles in HCC carcinogenesis. HBx interferes with several signaling pathways including Notch1 pathway in HCC. In our study, we found that Notch1 was highly expressed in HCC especially in large HCC. Notch1 and HBx co-localized in HCC and their levels were positively correlated with each other. Notch1 expression was more elevated in HepG2.2.15 than that in HepG2. HBx activated Notch1 pathway in HepG2.2.15. Repression of HBx and Notch1 pathway attenuated the growth of HepG2.2.15. Notch1, ERK and AKT pathways were inhibited after a γ-secretase inhibitor treatment. Dual-specificity phosphatase 1 (DUSP1) and phosphatase and tensin homolog (PTEN) were up-regulated after the γ-secretase inhibitor treatment and Hes1 inhibition. Luciferase reporter assays showed that Hes1 repressed the promoters of DUSP1 and PTEN and this was reverted by γ-secretase inhibitor treatment. Western blotting demonstrated that DUSP1 dephosphorylated pERK and PTEN dephosphorylated pAKT. Collectively, we reported a link among HBx, Notch1 pathway, DUSP1/PTEN, and ERK/AKT pathways, which influenced HCC cell survival and could be a therapeutic target for HCC. © 2017 Spandidos Publications. All rights reserved.

基金：

语种：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 3 区医学

小类 | 3 区肿瘤学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区肿瘤学

第一作者：

第一作者单位： [1]Department of General Surgery, Zhongnan Hospital, Wuhan University, 169 Donghu Road, Wuhan 430071, China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma [2]Notch1 promotes hepatitis B virus X protein-induced hepatocarcinogenesis via Wnt/β-catenin pathway [3]Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma [4]Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein- associated hepatocellular carcinoma [5]Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma [6]Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway [7]Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis [8]c-Jun N-terminal kinase inhibitor favors transforming growth factor-beta to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma [9]The hepatitis B virus X protein downregulates NF-kappa B signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells [10]乙肝病毒X蛋白对正常肝细胞生物钟基因表达的影响